2015


Zürich

Homepage

Company profile

Versantis

Versantis specialises in the diagnosis, prevention and treatment of liver diseases. The biotech startup has raised funds through various initiatives such as Venture Kick, and it completed a round of financing to the tune of more than CHF 4 million in spring. Versantis also managed to convince the US regulatory authorities, which granted the startup orphan drug status for its first drug. This will make it easier to conduct clinical trials and obtain approval.


Source: startup.ch

Highlights

More news about Versantis

17.07.2017 10:45

Versantis receives FDA Orphan Drug Designation

Success
Please login or
register to use the
bookmark feature
19.04.2017 09:20

15 Swiss startups to present at Swiss Biotech Day

BackgroundSupport
Please login or
register to use the
bookmark feature
29.03.2017 08:47

Versantis Raises CHF 4.4 Million in Series A Financing

Financing
Please login or
register to use the
bookmark feature
12.12.2016 15:45

18 startups selected for the Investor Summit 2017

Background
Please login or
register to use the
bookmark feature
10.10.2016 10:05

Ten Swiss startups among the MassChallenge finalists

Award
Please login or
register to use the
bookmark feature
02.09.2016 11:05

Biointerfaces: Vom Labor auf den Markt

Background
Please login or
register to use the
bookmark feature
06.06.2016 09:32

Orphan Drug Designation granted to Versantis

SuccessSupport
Please login or
register to use the
bookmark feature
19.05.2016 11:30

51 Swiss startups in the MassChallenge 2016 Cohort

Support
Please login or
register to use the
bookmark feature
13.04.2016 17:00

Five new CTI Startup label companies

Award
Please login or
register to use the
bookmark feature
29.01.2016 13:27

Versantis CEO gewinnt Pfizer Forschungspreis

Award
Please login or
register to use the
bookmark feature
04.02.2015 14:59

Versantis wins CHF130’000 at VENTURE KICK

Award
Please login or
register to use the
bookmark feature
24.10.2014 12:25

CEO Day: The centre of the Swiss start-up world

Please login or
register to use the
bookmark feature
23.10.2014 11:58

Die Finalisten des Swiss Technology Award stehen fest

Award
Please login or
register to use the
bookmark feature
12.09.2014 09:57

Western Swiss start-ups at the Swiss Exchange

Please login or
register to use the
bookmark feature
29.08.2014 14:25

Seven promising start-ups selected for next Swiss Venture Day (updated)

Please login or
register to use the
bookmark feature
25.07.2014 15:09

Volkswirtschaftsstiftung: 400‘000 Franken für Jungfirmen

Support
Please login or
register to use the
bookmark feature
20.03.2014 16:11

Swiss National Start-up Team Ready for a Trip to the US

Award
Please login or
register to use the
bookmark feature

Principal

Partners

Contributors

By continuing to use this website you agree with our TERMS AND CONDITIONS

In order to provide the best quality for you, our system uses "cookies", which are stored on your device. Cookies are necessary to identify what information (job advertisement, questionnaire, etc) you have already seen. IP address is used for the same purposes as described above.

When creating a profile, applying to the newsletter, job subscriptions and etc, you agree that the data, which you have entered, will be stored and processed in the system in order to provide services, which you have applied for.

We do NOT sell your personal data to any 3rd party services.

You must be 18 or older years old to use our services. If you are underage, you must have a permission to use our services from your parent or guardian. It is necessary in order to store and process your data.

By continuing to use our services, you agree with the these terms. You can withdraw your agreement at any time, by deleting cookies from your device and by sending request for deleting your data to the administrator.